The radiopharmaceutical market has emerged as one of the most significant segments in the healthcare industry, driven by advancements in nuclear medicine and increasing demand for targeted diagnostics ...

A trio of studies led by Indiana University School of Medicine researchers has found that digital testing during primary care ...

Findings suggest a simple eye exam could be a way to screen for dementia well before cognitive symptoms occur.

Alzheimer’s researcher Donald Weaver tells The Conversation Weekly podcast what he’s learnt during more than 30 years of ...

A readily available sleep aid has been shown to have a surprising side effect on brain health, seemingly protecting the organ ...

Dr. Richard G. Stefanacci explains why the FDA's recent clearance of a diagnostic blood test for Alzheimer's deserves ...

May 8, 2025 — The drugs, called NRTIs, have the potential to prevent a million cases of Alzheimer's every year, the researchers ... May 7, 2025 — Obstructive sleep apnea, a condition that ...

May 22, 2025 — Worldwide, more than 55 million people suffer from dementia caused by Alzheimer's Disease (AD) and other conditions that destroy cells in the brain and nervous system. While there ...

Malvern biotechnology company Fujirebio Diagnostics has developed a revolutionary new test to diagnose Alzheimer’s disease, writes Harold Brubaker for ...

Randall Bateman, MD, Charles F and Joanne Knight Distinguished Professor of Neurology at WashU Medicine. A study of Roche's anti-amyloid drug gantenerumab has suggested that early treatment to ...

Cassava Sciences' troubled development of Alzheimer's disease candidate simufilam looks like it may have finally reached the end. The Austin, Texas-based biotech revealed that simufilam failed its ...